Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6R-BH4 in Isolated Systolic Hypertension
NCT00802893Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Dec 2008
- Primary completion
- May 2009
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in isolated systolic hypertension (ISH), endothelial dysfunction, sponsored by Johns Hopkins University. Started Dec 2008; status: terminated.
02
Drugs
sapropterin
03
Conditions
isolated systolic hypertension (ISH)endothelial dysfunction
Beyond the preview
Go deeper on NCT00802893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802893.